Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIGF-1 and Estrogen for Bone Mass in Anorexia Nervosa
NCT01301183Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2011
- Primary completion
- Mar 2019
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of mecasermin in anorexia nervosa (AN), sponsored by Massachusetts General Hospital. Started Feb 2011; status: completed.
02
Drugs
mecasermin
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT01301183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01301183.